INOVIA® Vein Specialty Center will be the first in Oregon to treat patients with venous reflux disease using the VenaSeal™ closure system. The VenaSeal™ closure system is a new, minimally invasive procedure that uses an advanced medical adhesive to close the diseased vein in patients with symptomatic venous reflux disease.
Drs. Andrew Jones and Edward Boyle of INOVIA® Vein Specialty Center participated in the national Veclose trial, a randomized control trial comparing VenaSeal Closure System to Radiofrequency Ablation. The results of this trial demonstrated the VenaSeal is safe and effective, with a 97.2% closure rate of the treated veins at one year. The results were presented at American College of Phlebology Annual Congress in Phoenix, Arizona by Dr. Andrew Jones. In addition, Dr. Andrew Jones authored the clinical trial results, published in the Journal of Vascular Surgery in January 2015.
Venous reflux disease affects more than 30 million Americans. It occurs when valves in the veins of the lower leg no longer function properly. This allows blood to flow backward, or reflux, resulting in enlarged, or varicose veins as well as other symptoms. “Varicose veins may be a sign of a more serious condition known as chronic venous insufficiency, which in severe cases, can result in lifestyle-limiting lower leg pain, swelling, skin damage, and ulcerations,” said Dr Andrew Jones.
The VenaSeal™ closure system is a new and innovative treatment option that improves blood flow by closing the diseased vein. The system has demonstrated effective clinical results and patients can often quickly return to normal activities.”
The VenaSeal™ procedure is the only procedure to use medical adhesive to coapt and close the vein, with high closure rates across three clinical trials. Additionally, patients treated with the VenaSeal™ closure system often have minimal to no bruising, and can return quickly to normal activities. Unlike other heat based treatments, the VenaSeal™ closure system does not require tumescent anesthesia (multiple injections of a dilute local anesthetic), and eliminates the risk of burning or nerve injury associated with thermal based procedures. In some cases, patients also may not need to use compression stockings after the procedure.
Those interested in learning more about venous reflux disease and the VenaSeal™ closure system can contact INOVIA® Vein Specialty Center today at 541-382-8346 to schedule an appointment to learn more about venous reflux disease and treatment with the VenaSeal™ closure system.